ATN 160: TechStep resumed enrollment at some sites on 9/22/2020 after pausing in response to the COVID-19 pandemic. The protocol has been adjusted to allow remote enrollments and in-home specimen collection.
TechStep is currently enrolling in Los Angeles, Boston, and New York City and enrollment will reopen soon in Houston and Philadelphia.
The research study is is a two-condition, technology-based randomized controlled trial (RCT), with a stepped care approach, among high-risk HIV-negative trans feminine, trans masculine, and gender non-conforming (here after: trans*) youth for reducing sexual risk behaviors (e.g., condomless anal intercourse, engagement in sex work, sex while feeling the effects of alcohol or drugs) and increasing PrEP uptake.